Answers are grounded in this paper and cite their sources.
Peripheral nerve injury is a prevalent pathology that is often associated with trauma. Nerve regeneration after injury can result in dysregulated growth or scarring that results in a neuroma, or a painful growth of nerve tissue. Targeted muscle reinnervation (TMR) is an effective strategy to treat and prevent neuroma-related pain, although outcomes remain variable, likely attributable to ongoing inflammation and fibrosis at the reconstruction site. Amniotic membranes have been successfully used as a tissue engineering solution in other sub-specialties and contain several growth factors implicated in fibrosis regulation and reduction in scarring with various types of tissues. Yet, the influence of ultra-thick amniotic membranes on behavior and on pain- and regeneration-associated neuronal biomarkers following nerve reconstruction via TMR remains underexplored. A rat model of symptomatic tibial neuroma was established via nerve transection. After 6 weeks, animals were assigned to negative control (CTRL; n = 8 rats), TMR (n = 8 rats), or TMR with ultra-thick amniotic membrane (TMRA; n = 6 rats; Clarix® 1K ultra-thick human amniotic membrane, BioTissue, Miami, FL, USA). Subjects were allowed to heal for 10 weeks following intervention. Neuroma creation produced significant increases in tactile (von Frey) and cold (acetone) allodynia versus baseline (p < 0.001). TMRA demonstrated significantly reduced cold allodynia compared with CTRL and TMR after 16 weeks (p < 0.001), and reduced DRG expression of regeneration-related markers, namely, activating transcription factor 3 (p < 0.001) and phosphorylated cyclic AMP response element-binding protein (p < 0.001) relative to CTRL and TMR alone. Additionally, TMRA demonstrated significantly lower expression of pain-related biomarker Iba1 at the coaptation site compared with both CTRL and TMR (p ≤ 0.033). Taken together, these results support ultra-thick amniotic membrane wrapping as a promising TMR adjunct in the management of postamputation and post-traumatic neuroma pain.
No takes yet. Share an insight, caveat, or question.
Iglesias et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: